Effective combinatorial immunotherapy for castration-resistant prostate cancer (vol 543, pg 728, 2017)

被引：7
|
作者：
Lu, Xin
Horner, James W.
Paul, Erin
Shang, Xiaoying
Troncoso, Patricia
Deng, Pingna
Jiang, Shan
Chang, Qing
Spring, Denise J.
Sharma, Padmanee
Zebala, John A.
Maeda, Dean Y.
Wang, Y. Alan
DePinho, Ronald A.
机构：
来源：
NATURE | 2017年 / 545卷 / 7652期
关键词：
D O I：
10.1038/nature22348
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Nature 543, 728–732 (2017); doi:10.1038/nature21676 In this Letter, owing to an error during the production process, the x-axis label ‘BEZ + ICB’ appeared twice in each of the graphs in Fig. 1d–f, and the ‘Cabo + ICB’ label was missing. In each graph, the first ‘BEZ + ICB’ label should have read ‘Cabo + ICB’.
引用
收藏
页码：116 / 116
页数：1
相关论文
共 50 条
  • [21] Advances in immunotherapy of castration-resistant prostate cancer: Bisphosphonates, phosphoantigens and more
    Dieli, Francesco
    Caccamo, Nadia
    Meraviglia, Serena
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (10) : 1089 - 1094
  • [22] Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer REPLY
    Kantoff, Philip W.
    Frohlich, Mark W.
    Schellhammer, Paul F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (20): : 1967 - 1968
  • [23] Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
    Kantoff, Philip W.
    Higano, Celestia S.
    Shore, Neal D.
    Berger, E. Roy
    Small, Eric J.
    Penson, David F.
    Redfern, Charles H.
    Ferrari, Anna C.
    Dreicer, Robert
    Sims, Robert B.
    Xu, Yi
    Frohlich, Mark W.
    Schellhammer, Paul F.
    Ahmed, T.
    Amin, A.
    Arseneau, J.
    Barth, N.
    Bernstein, G.
    Bracken, B.
    Burch, P.
    Caggiano, V.
    Chin, J.
    Chodak, G.
    Chu, F.
    Corman, J.
    Curti, B.
    Dawson, N.
    Deeken, J. F.
    Dubernet, T.
    Fishman, M.
    Flanigan, R.
    Gailani, F.
    Garbo, L.
    Gardner, T.
    Gelmann, E.
    George, D.
    Godfrey, T.
    Gomella, L.
    Guerra, M.
    Hall, S.
    Hanson, J.
    Israeli, R.
    Jancis, E.
    Jewett, M. A. S.
    Kassabian, V.
    Katz, J.
    Klotz, L.
    Koeneman, K.
    Koh, H.
    Kratzke, R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (05): : 411 - 422
  • [24] Immunotherapy for castration-resistant prostate cancer: has its time arrived?
    Slovin, Susan F.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (05) : 481 - 487
  • [25] Immunotherapy and endothelin receptor antagonists for treatment of castration-resistant prostate cancer
    Shao, Ning
    Wang, Yang
    Jiang, Wen Yu
    Qiao, Di
    Zhang, Shi Ge
    Wu, Ye
    Zhang, Xiang Xiang
    Wang, Jiu Ling
    Ding, Yi
    Feng, Ning Han
    INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (07) : 1743 - 1750
  • [26] Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer
    Arshad, Osama A.
    Datta, Aniruddha
    PROCEEDINGS OF THE 7TH ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY, AND HEALTH INFORMATICS, 2016, : 529 - 529
  • [27] Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer
    Arshad, Osama Ali
    Datta, Aniruddha
    BMC BIOINFORMATICS, 2017, 18
  • [28] Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer
    Osama Ali Arshad
    Aniruddha Datta
    BMC Bioinformatics, 18
  • [29] Darolutamide For Castration-Resistant Prostate Cancer
    Bastos, Diogo A.
    Antonarakis, Emmanuel S.
    ONCOTARGETS AND THERAPY, 2019, 12 : 8769 - 8777
  • [30] Metastatic castration-resistant prostate cancer
    Henriques, Vanessa
    Wenzel, Mike
    Demes, Melanie-Christin
    Koellermann, Jens
    PATHOLOGE, 2021, 42 (04): : 431 - 438
12345